SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-291681
Filing Date
2020-11-12
Accepted
2020-11-12 16:16:20
Documents
57
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d24902d10q.htm 10-Q 901811
2 EX-10.7 d24902dex107.htm EX-10.7 74237
3 EX-31.1 d24902dex311.htm EX-31.1 11499
4 EX-31.2 d24902dex312.htm EX-31.2 11533
5 EX-32.1 d24902dex321.htm EX-32.1 6924
12 GRAPHIC g24902dspstmp006.jpg GRAPHIC 22110
13 GRAPHIC g24902g21p16.jpg GRAPHIC 8719
  Complete submission text file 0001193125-20-291681.txt   3961976

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rlay-20200930.xml EX-101.INS 766072
7 XBRL TAXONOMY EXTENSION SCHEMA rlay-20200930.xsd EX-101.SCH 31533
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rlay-20200930_cal.xml EX-101.CAL 27723
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rlay-20200930_def.xml EX-101.DEF 143067
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlay-20200930_lab.xml EX-101.LAB 280069
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlay-20200930_pre.xml EX-101.PRE 222635
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 201306902
SIC: 2836 Biological Products, (No Diagnostic Substances)